ZA200806548B - A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions - Google Patents

A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions

Info

Publication number
ZA200806548B
ZA200806548B ZA200806548A ZA200806548A ZA200806548B ZA 200806548 B ZA200806548 B ZA 200806548B ZA 200806548 A ZA200806548 A ZA 200806548A ZA 200806548 A ZA200806548 A ZA 200806548A ZA 200806548 B ZA200806548 B ZA 200806548B
Authority
ZA
South Africa
Prior art keywords
biocompatible
biodegradable
pharmaceutical compositions
polymer useful
toxic polymer
Prior art date
Application number
ZA200806548A
Other languages
English (en)
Inventor
Anand C Burman
Rama Mukherjee
Dhiraj Khattar
Sanjoy Mullick
Manu Jaggi
Manoj Kumar Singh
Mukesh Kumar
Deepak Prusthy
Pawan Kumar Gupta
Rajendran Praveen
Shobhit Singh
Original Assignee
Dabur Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Pharma Ltd filed Critical Dabur Pharma Ltd
Publication of ZA200806548B publication Critical patent/ZA200806548B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/56—Acrylamide; Methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/04—Anhydrides, e.g. cyclic anhydrides
    • C08F222/06—Maleic anhydride
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10—Esters
    • C08F222/12—Esters of phenols or saturated alcohols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/06—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
    • C08F226/10—N-Vinyl-pyrrolidone
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/36—Amides or imides
    • C08F222/38—Amides
    • C08F222/385—Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200806548A 2005-12-28 2006-12-26 A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions ZA200806548B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1190KO2005 2005-12-28

Publications (1)

Publication Number Publication Date
ZA200806548B true ZA200806548B (en) 2010-02-24

Family

ID=37845115

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200806548A ZA200806548B (en) 2005-12-28 2006-12-26 A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions

Country Status (19)

Country Link
US (2) US8338562B2 (de)
EP (2) EP2172497B1 (de)
JP (1) JP2009522251A (de)
KR (2) KR20080091158A (de)
CN (1) CN101336256B (de)
AR (1) AR058866A1 (de)
AT (1) ATE529454T1 (de)
AU (1) AU2006329554C1 (de)
BR (1) BRPI0620745A2 (de)
CA (1) CA2635469A1 (de)
EA (1) EA017682B1 (de)
ES (2) ES2375740T3 (de)
IL (1) IL192423A0 (de)
MX (1) MX2008008423A (de)
MY (1) MY148575A (de)
NZ (1) NZ569372A (de)
PH (1) PH12012502181A1 (de)
WO (1) WO2007074476A1 (de)
ZA (1) ZA200806548B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009522251A (ja) 2005-12-28 2009-06-11 ダブール・ファーマ・リミテッド ナノ粒子医薬組成物に有用な生体適合性、非生物分解性、非毒性ポリマー
JP5420946B2 (ja) * 2009-03-23 2014-02-19 富士フイルム株式会社 胆汁酸を含むミノキシジル水性組成物
CN101845120B (zh) * 2010-03-25 2011-11-16 淮阴师范学院 一种温敏和生物可降解性原位凝胶的合成方法
US8772355B2 (en) 2010-11-23 2014-07-08 Howard University Stealth polymeric particles for delivery of bioactive or diagnostic agents
US8921429B2 (en) 2010-11-23 2014-12-30 Howard University Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2859090A4 (de) * 2012-06-07 2015-11-25 David K Moscatello Zusammensetzungen und verfahren zur entnahme, reinigung, kryokonservierung, rückgewinnung und rückgabe von lipoaspiraten an den arzt für autologe fettgewebeübertragung
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US20150351428A1 (en) * 2014-06-04 2015-12-10 Animal Science Products, Inc. Methods and compositions for orally dosing postnatal swine
CN104119475B (zh) * 2014-06-26 2016-06-15 中国人民解放军第三○九医院 一种表面功能化的微纳米聚合物凝胶粒子及其制备方法
CN104119474B (zh) * 2014-06-26 2016-06-15 中国人民解放军第三○九医院 一种表面功能化的微纳米聚合物空心粒子及其制备方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10176182B2 (en) 2015-08-31 2019-01-08 International Business Machines Corporation File deletion in storage devices based on the deletion priority rules
EP3153227A1 (de) * 2015-10-07 2017-04-12 Evonik Degussa GmbH Verfahren zur herstellung von polyalkenameren für verpackungsanwendungen
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US636519A (en) 1899-04-14 1899-11-07 Elisha Gray Transmission of sound.
JP2517760B2 (ja) 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
KR940003548U (ko) 1992-08-14 1994-02-21 김형술 세탁물 건조기
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5439686A (en) 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US6096331A (en) 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US5362478A (en) 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5916596A (en) 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6537579B1 (en) 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US5874111A (en) 1997-01-07 1999-02-23 Maitra; Amarnath Process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles
IT1293823B1 (it) * 1997-08-05 1999-03-10 Stefano Gasparini Materiale plastico non tossico avente proprieta' di adsorbenza e assorbenza e relativo procedimento di fabbricazione
US6403816B1 (en) 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
US5830964A (en) * 1997-12-18 1998-11-03 Isp Investments Inc. Vinyl pyrrolidone polymers substantially free of vinyl lactam monomers
IN191203B (de) * 1999-02-17 2003-10-04 Amarnath Prof Maitra
US6365191B1 (en) 1999-02-17 2002-04-02 Dabur Research Foundation Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
US6617420B2 (en) * 2000-08-11 2003-09-09 Nippon Shokubai Co., Ltd. Process for reducing monomer content in N-vinyl compound polymers
US8545830B2 (en) 2003-03-24 2013-10-01 University Of Tennessee Research Foundation Multi-functional polymeric materials and their uses
JP2009522251A (ja) 2005-12-28 2009-06-11 ダブール・ファーマ・リミテッド ナノ粒子医薬組成物に有用な生体適合性、非生物分解性、非毒性ポリマー
WO2008073558A2 (en) * 2006-10-05 2008-06-19 The Johns Hopkins University Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles

Also Published As

Publication number Publication date
EP2172497B1 (de) 2013-05-22
AU2006329554A1 (en) 2007-07-05
WO2007074476A1 (en) 2007-07-05
US20130274211A1 (en) 2013-10-17
CA2635469A1 (en) 2007-07-05
NZ569372A (en) 2011-10-28
BRPI0620745A2 (pt) 2013-02-19
MY148575A (en) 2013-04-30
IL192423A0 (en) 2008-12-29
EA017682B1 (ru) 2013-02-28
ES2425075T3 (es) 2013-10-11
ES2375740T3 (es) 2012-03-05
MX2008008423A (es) 2008-09-23
CN101336256A (zh) 2008-12-31
EA200801563A1 (ru) 2009-06-30
ATE529454T1 (de) 2011-11-15
PH12012502181A1 (en) 2015-06-26
AU2006329554C1 (en) 2013-06-20
EP1971622B1 (de) 2011-10-19
AR058866A1 (es) 2008-02-27
AU2006329554B2 (en) 2013-01-10
EP2172497A1 (de) 2010-04-07
KR20130116954A (ko) 2013-10-24
KR20080091158A (ko) 2008-10-09
CN101336256B (zh) 2012-03-28
US8338562B2 (en) 2012-12-25
EP1971622A1 (de) 2008-09-24
US20090318661A1 (en) 2009-12-24
US8927023B2 (en) 2015-01-06
HK1123814A1 (en) 2009-06-26
JP2009522251A (ja) 2009-06-11

Similar Documents

Publication Publication Date Title
IL192423A0 (en) A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions
EP2046885A4 (de) Abformbares biologisch abbaubares polymer
IL182405A0 (en) Mouldable biodegradable polymer
IL233925A (en) Pharmaceutical dose for oral administration in the form of tiny particles to prevent misuse
IL188964A0 (en) Sustained drug release composition
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
EP1868610A4 (de) Biologisch verträgliche polymerverbindungen für medizinische formulierungen
ZA200806443B (en) A molecular sieve composition
IL185197A0 (en) Ophthalmological pharmaceutical compositions
IL193774A0 (en) Pharmaceutical compositions containing a 3,5-seco-4-norcholestane derivative
PL1924150T3 (pl) Biodegradowalna guma do żucia
EP2025667A4 (de) 9, 10-secopregnanderivat und arzneimittel
EP1976930A4 (de) Polymerlegierungszusammensetzung
SI2231598T1 (sl) Novi derivati diazeniumdiolata postopek pripravele teh in njihovi farmacevtski sestavki
EP1960446A4 (de) Biokompatible chirurgische zusammensetzungen
PL1947958T3 (pl) Degradowalna guma do żucia
EP1988124A4 (de) Polymerzusammensetzung
HU0500683D0 (en) New arylpiprazole salts for producing pharmaceutical composition
HUP0600198A3 (en) Duloxetine salts for producing pharmaceutical compositions, their preparation, use and impurirites
IL188871A0 (en) Packaging for condoms
ZA200706807B (en) Composition containing chitosan for sustained drug release
GB0511841D0 (en) Polymer formulations
GB0508640D0 (en) Biodegradable gum
AU2006904181A0 (en) Biocompatible polymer compositions
AU2006904182A0 (en) Biocompatible polymer compositions